©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2023; 11(20): 4734-4739
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4734
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4734
Inflammatory myofibroblastic tumor of the distal common bile duct: Literature review with focus on pathological examination
Fleur Cordier, Anne Hoorens, Liesbeth Ferdinande, Jo Van Dorpe, David Creytens, Department of Pathology, Ghent University Hospital, Ghent 9000, Belgium
Author contributions: Cordier F performed the writing of the paper and made the figures; Creytens D performed the study concept, design and review of the paper; Hoorens A, Ferdinande L and Van Dorpe J performed review of the paper; all authors read and approved the final paper.
Conflict-of-interest statement: The authors state that there are no conflicts of interests to disclose.
Corresponding author: David Creytens, MD, PhD, Department of Pathology, UZ Ghent, Corneel Heymanslaan 10 B-9000 Ghent Belgium, Ghent 9000, Belgium.
Received: February 17, 2023
Peer-review started: February 17, 2023
First decision: May 18, 2023
Revised: May 31, 2023
Accepted: June 26, 2023
Article in press: June 26, 2023
Published online: July 16, 2023
Processing time: 144 Days and 16.8 Hours
Peer-review started: February 17, 2023
First decision: May 18, 2023
Revised: May 31, 2023
Accepted: June 26, 2023
Article in press: June 26, 2023
Published online: July 16, 2023
Processing time: 144 Days and 16.8 Hours
Core Tip
Core Tip: Inflammatory myofibroblastic tumor (IMT) of the intrapancreatic biliary tract is rare and often difficult to diagnose. In this manuscript, we give a recent update of the clinicopathological features of IMT with focus on the pathological and molecular characteristics.